Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

445
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
445
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

2.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.3K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

173
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
173
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

253
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
253
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

667
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
667
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.0K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Domain-specific adaptation for MR image synthesis with text-guided diffusion.

Physics in medicine and biology·2026
Same author

Isavuconazole provides effective and tolerable antifungal prophylaxis for patients with acute myeloid leukemia.

Leukemia research·2025
Same author

Automated system of analysis to quantify pediatric hip morphology.

Computers in biology and medicine·2025
Same author

The utility of intravenous immunoglobulin infection prophylaxis in patients on anti-CD38 therapies.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2025
Same author

A review of the isocitrate dehydrogenase inhibitors in management of adult patients with AML and MDS.

Expert review of hematology·2024
Same author

Automatic Segmentation of the Paediatric Femoral Head.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same journal

Retrospective Characterization of Specialized Palliative Care in Patients With Gliomas.

Journal of the advanced practitioner in oncology·2026
Same journal

Distress Screening in a Cancer Survivorship Clinic: Impact on Psychosocial Referrals.

Journal of the advanced practitioner in oncology·2026
Same journal

Building Bridges: The Impact of Medical Science Liaison and Advanced Practice Provider Collaborations.

Journal of the advanced practitioner in oncology·2026
Same journal

Advances in Hodgkin Lymphoma Treatment: Clinical Considerations for Managing Toxicities in Nivolumab-AVD Therapy.

Journal of the advanced practitioner in oncology·2026
Same journal

Colorectal Cancer Treatment During Pregnancy.

Journal of the advanced practitioner in oncology·2026
Same journal

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma.

Journal of the advanced practitioner in oncology·2026
See all related articles

Related Experiment Video

Updated: Nov 19, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.3K

Precautions for Patients Taking Aromatase Inhibitors.

Mary Heery1, Stephen Farley2, Rhett Sparkman2

  • 1Western Connecticut Health Network at The Smilow Family Breast Health Center, Norwalk Hospital, Norwalk, Connecticut.

Journal of the Advanced Practitioner in Oncology
|February 3, 2021
PubMed
Summary
This summary is machine-generated.

Aromatase inhibitors effectively treat hormone-sensitive breast cancer in postmenopausal women. Patient education on managing side effects is crucial for treatment adherence.

More Related Videos

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.9K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.7K

Related Experiment Videos

Last Updated: Nov 19, 2025

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
08:46

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

6.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

5.9K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.7K

Area of Science:

  • Oncology
  • Endocrinology
  • Pharmacology

Background:

  • Aromatase inhibitors are primary treatments for estrogen receptor-positive breast cancer in postmenopausal women.
  • Aromatase enzyme is key in estrogen biosynthesis, making its inhibitors effective cancer therapies.
  • Clinical trials confirm the benefits of aromatase inhibitors.

Purpose of the Study:

  • To highlight the importance of patient education for aromatase inhibitor therapy.
  • To address challenges in adherence to aromatase inhibitor treatment.

Main Methods:

  • Review of clinical trial data on aromatase inhibitors.
  • Analysis of factors affecting patient adherence.

Main Results:

  • Aromatase inhibitors demonstrate significant efficacy in breast cancer treatment.
  • Patient adherence can be hindered by drug interactions and side effects.

Conclusions:

  • Comprehensive patient education is vital for managing adverse effects and improving adherence.
  • Effective management strategies are essential for successful aromatase inhibitor therapy.